Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PLC Systems' CO2 Heart Laser deemed effective in angina patients

June 28, 1996

Phospholipase A2 inhibitors for atherosclerosis treatment

June 28, 1996

Sankyo will seek FDA approval for temocapril HCl in 1997

June 28, 1996

Neurex seeks FDA approval for Corlopam

June 28, 1996

Endothelin antagonists in Kyowa Hakko's pipeline

June 28, 1996

Angiotensin II antagonists described by Sankyo

June 28, 1996

Roberts' ProAmatine approaches FDA approval

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

L-arginine is effective in heart failure patients

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...